-

Owens & Minor Intends to Sell Movianto Business

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) announces today its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company and one of Europe’s leading providers of healthcare logistics services.

“Owens & Minor is laser-focused on our mission to empower our customers to advance healthcare. While Movianto has been an important part of the Owens & Minor family, the intended transaction would advance Owens & Minor’s mission by providing greater ability to focus on and invest in our differentiated products, services and US distribution businesses,” said Ed Pesicka, CEO of Owens & Minor.

“The quality of operations, the solid reputation and the values of Movianto are perfectly consistent with EHDH,” said Stéphane Baudry, CEO of EHDH. “This potential combination of EHDH and Movianto comes at a key moment in our development and in response to market demand for a single contact to handle all logistics and transport services at European level.”

The intended transaction is subject to discussions, where mandated, with employee representative bodies and certain conditions, including customary regulatory and other approvals. Subject to these, the intended transaction would be expected to close in the first half of 2020. Sale proceeds are intended to be used toward debt reduction.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company with integrated technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. With 17,000 dedicated teammates serving healthcare industry customers in 90 countries, Owens & Minor helps to reduce total costs across the supply chain by optimizing episode and point-of-care performance, freeing up capital and clinical resources, and managing contracts to optimize financial performance. A FORTUNE 500 company, Owens & Minor was founded in 1882 in Richmond, Virginia, where it remains headquartered today. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter, and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

About EHDH

EHDH is a global service provider in the field of logistics and transport in the pharmaceutical sector and B2B express delivery. With integrated proprietary technology, strategic infrastructure and solid expertise in the healthcare sector, EHDH operates all the businesses essential to a reliable, agile and efficient supply chain in the pharmaceutical sector. Supported by organic growth and successful acquisitions, the group offers turnkey support to all healthcare players, encompassing logistics, transport, value-added services and IT services.

EHDH is an independent privately owned company founded in 1951 by Marcel Baudry and managed today by his grandson, Stéphane Baudry. EHDH employs 2,600 people spread over more than 300,000 square meters in 160 locations in France and Benelux. The group has a cumulative turnover of 650 million euros and aims to accelerate its development in France and abroad.

Contacts

Chuck Graves, Director, Finance & Investor Relations, Owens & Minor; 804.723.7556; chuck.graves@owens-minor.com

Owens & Minor

NYSE:ACH
Details
Headquarters: Richmond, VA
CEO: Edward Pesicka
Employees: 6000
Organization: PUB

Release Summary
Owens & Minor Intends to Sell Movianto Business
Release Versions
$Cashtags

Contacts

Chuck Graves, Director, Finance & Investor Relations, Owens & Minor; 804.723.7556; chuck.graves@owens-minor.com

More News From Owens & Minor

Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with the NYSE’s continued listing standards because the average closing price of the Company’s Class A Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period. The Notice does not result in the im...

Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer. Gardner-Smith, who has served on the Company’s Board of Directors since March 2022, is expected to assume the role early in the fourth quarter 2026. He will succeed Edward A. Pesicka, who announced his intent to retire in August. Gardner-Smith brings deep experience running large-scale patient care operations and guiding...

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health (the “Company”) is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer. Given recent market conditions, the Company has determined that it is in the best interest of stakeholders not to put in place an at-the-market issuance program. The program was intended to allow the Company to opportunistically issue modest amounts of equity over time, with the proceeds to be used to reduce o...
Back to Newsroom